Literature DB >> 3656333

Pericardial effusion complicating breast cancer.

P J Woll1, R K Knight, R D Rubens.   

Abstract

Thirty-five patients with metastatic breast cancer and pericardial effusions are described. They were treated with specific endocrine or chemotherapy. Twenty-two (63%) had presented in cardiac tamponade and were rapidly relieved by pericardiocentesis. Eighteen (82%) of these required no further local treatment, 2 obtained relief from a second aspiration and 2 needed additional treatment (intrapericardial bleomycin instillation and surgical pleuropericardial window). The median survival was 13.2 months. No patient relapsed again in the pericardium, suggesting that their prognosis was that of the underlying disease. Cardiac tamponade should be considered in any breathless patient with malignancy. In breast cancer, periocardiocentesis is lifesaving and systemic treatment can usefully prolong life.

Entities:  

Mesh:

Year:  1987        PMID: 3656333      PMCID: PMC1290954          DOI: 10.1177/014107688708000811

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  14 in total

1.  The management of malignant pericardial effusions.

Authors:  J J Lokich
Journal:  JAMA       Date:  1973-06-04       Impact factor: 56.272

2.  Intrapericardial installation of radioactive chromic phosphate in malignant effusion.

Authors:  N Martini; A H Freiman; R C Watson; B S Hilaris
Journal:  AJR Am J Roentgenol       Date:  1977-04       Impact factor: 3.959

3.  The management of cardiac tamponade in patients with breast cancer.

Authors:  J D Bitran; R Evans; C Brown
Journal:  J Surg Oncol       Date:  1984-09       Impact factor: 3.454

4.  Brain metastases from breast cancer: clinical course, prognosis and influence of treatment.

Authors:  G E Sparrow; R D Rubens
Journal:  Clin Oncol       Date:  1981-12

5.  The natural history of breast cancer patients with brain metastases.

Authors:  A DiStefano; Y Yong Yap; G N Hortobagyi; G R Blumenschein
Journal:  Cancer       Date:  1979-11       Impact factor: 6.860

6.  The natural history of lung cancer with pericardial metastases.

Authors:  M A Quraishi; J J Costanzi; J Hokanson
Journal:  Cancer       Date:  1983-02-15       Impact factor: 6.860

7.  Pericardial disease in patients with cancer. The differentiation of malignant from idiopathic and radiation-induced pericarditis.

Authors:  M R Posner; G I Cohen; A T Skarin
Journal:  Am J Med       Date:  1981-09       Impact factor: 4.965

8.  Causes of death in breast cancer: a clinicopathologic study.

Authors:  F B Hagemeister; A U Buzdar; M A Luna; G R Blumenschein
Journal:  Cancer       Date:  1980-07-01       Impact factor: 6.860

9.  The treatment of malignant pericardial effusion in carcinoma of the breast.

Authors:  P M Reynolds; M J Byrne
Journal:  Aust N Z J Med       Date:  1977-04

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  1 in total

1.  Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study.

Authors:  Mie Kotake; Hisao Imai; Kyoichi Kaira; Tomomi Fujisawa; Yasuhiro Yanagita; Koichi Minato
Journal:  Cancer Chemother Pharmacol       Date:  2019-06-27       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.